James Huang - 30 Jun 2025 SCHEDULE 13G/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI)

Filing Manager
James Huang
Reporting Manager
James Huang
Security
CASI Pharmaceuticals, Inc. Ordinary Shares
Symbol
CASI
Shares outstanding
15,663,558 shares
Disclosed Ownership
2,161,571 shares
Ownership
14%
Form type
SCHEDULE 13G/A
Filing time
23 Jul 2025, 09:39:43 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"James Huang disclosed 14% ownership in CASI Pharmaceuticals, Inc. Ordinary Shares (CASI) on 30 Jun 2025."

Quick Takeaways

  • James Huang filed SCHEDULE 13G/A for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI).
  • Disclosed ownership: 14%.
  • Date of event: 30 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 23 Jul 2025, 09:39.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Panacea Venture Healthcare Fund II, L.P. 13% 2,050,000 0 2,050,000 By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner
Panacea Venture Healthcare Fund II GP Company, Ltd. 13% 2,050,000 0 2,050,000 By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner
Panacea Innovation Limited 13% 2,050,000 0 2,050,000 /s/ James Huang James Huang, Founding Managing Partner
James Huang 14% 2,161,571 111,571 2,050,000 /s/ James Huang James Huang

Sponsored